. . . . . . . . . . . . "[Overall, these studies have paved the way for the commercial development of PTP1B inhibitors that may serve as a novel type of `insulin sensitizer` in the management of type 2 diabetes and the cardiovascular / metabolic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2014-02-25"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2014-10-02T12:35:23+02:00"^^ . . . . . . . . . . . "v2.1.0.0" . "v2.1.0" .